
Lepidine | CAS:491-35-0
Lepidine
- 名称:4-甲基喹啉 | Lepidine
- CAS号:491-35-0
- 别名:4-Methylquinoline
- 分子式:C10H9N
- 分子量:143.19
- EINESC号:207-734-2
产品描述
物理化学性质
熔点 | 9-10 ºC |
---|---|
水溶性 | 微溶 |
沸点 | 261-263 ºC |
密度 | 1.083 |
折射率 | 1.618-1.62 |
安全数据
危险品标志 | Xn |
---|---|
危险类别码 | R36/37/38;R68 |
安全说明书 | S26;S36/37/39;S45 |
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Effects of L-glutamate, substance P and substance P(1-7) on cardiovascular regulation in the nucleus tractus solitarius.M E Hall et al.Regulatory peptides, 46(1-2), 102-109 (1993-07-02)
Inhibition of ERK phosphorylation by substance P N-terminal fragment decreases capsaicin-induced nociceptive response.Takaaki Komatsu et al.Neuropharmacology, 61(4), 608-613 (2011-05-24)
Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.Qin Zhou et al.Neuroscience letters, 320(3), 117-120 (2002-02-20)
Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord.Milad Botros et al.Peptides, 27(4), 753-759 (2005-10-12)
The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal.Qin Zhou et al.Peptides, 25(11), 1951-1957 (2004-10-27)
The C-terminal amidated analogue of the substance P (SP) fragment SP(1-7) attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats.Qin Zhou et al.Peptides, 30(12), 2418-2422 (2009-08-19)
Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors.Anna Carlsson et al.European journal of pharmacology, 626(2-3), 250-255 (2009-10-20)
Substance P N-terminal fragment SP(1-7) attenuates chronic morphine tolerance and affects dynorphin B and nociceptin in rats.Qin Zhou et al.Peptides, 32(8), 1661-1665 (2011-07-19)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!